Jo Craig
Senior Vice President, Cmc - Nerre Therapeutics @Nerre Therapeutics Ltd
Signup · Get unlimited contacts
WORK HISTORY
Senior Vice President, Cmc - Nerre Therapeutics @Nerre Therapeutics Ltd
Accountable for the overall CMC strategy and delivery for both NeRRe Therapeutics and KaNDy Therapeutics. Member of the leadership team for both companies.
EDUCATION
School of Pharmacy, U. of London
BPharm (Hons), Pharmacy
SKILLS
ABOUT JO CRAIG
Experienced senior leader in the Pharmaceutical Industry, large Pharma and Biotech, with a proven track record of leadership, innovation and delivery across CMC product and technology development. Currently SVP, CMC for NeRRe Therapeutics with accountability for the overall CMC strategy and delivery. Previously SVP, CMC for KaNDy Therapeutics prior to the successful acquisition by Bayer. Over 30 years at GlaxoSmithKline in leadership roles in CMC product development, manufacturing and quality.Member of the Advisory Group for the Innovate UK Medicines Manufacturing Challenge fund, and previously a member of Medicines Manufacturing Industry Partnership (MMIP), influential in aligning Pharma and UK Government on future areas for investment as part of the delivery of the UK Life Sciences Industrial Strategy. Currently, Chair of the Board for the Academy of Pharmaceutical Sciences (ASP), UK.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.